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PHYSIOLOGY

Role of Biﬁdobacterium pseudocatenulatum in Degradation and
Consumption of Xylan-Derived Carbohydrates
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Xylans, a family of xylose-based polysaccharides, are dietary ﬁbers resistant to digestion. They therefore reach the large intestine intact; there, they are utilized by members of the gut microbiota. They are initially broken down by primary
degraders that utilize extracellular xylanases to cleave xylan into smaller oligomers. The
resulting xylooligosaccharides (XOS) can either be further metabolized directly by primary degraders or cross-feed secondary consumers, including Biﬁdobacterium. While several Biﬁdobacterium species have metabolic systems for XOS, most grow poorly on longer-chain XOS and xylan substrates. In this study, we isolated strains of Biﬁdobacterium
pseudocatenulatum and observed that some, including B. pseudocatenulatum ED02, displayed growth on XOS with a high degree of polymerization (DP) and straight-chain
xylan, suggesting a primary degrader phenotype that is rare in Biﬁdobacterium. In silico
analyses revealed that only the genomes of these xylan-fermenting (xylan1) strains contained an extracellular GH10 endo- b -1.4 xylanase, a key enzyme for primary degradation
of xylan. The presence of an extracellular xylanase was conﬁrmed by the appearance of
xylan hydrolysis products in cell-free supernatants. Extracellular xylanolytic activity was
only detected in xylan1 strains, as indicated by the production of XOS fragments with a
DP of 2 to 6, identiﬁed by thin-layer chromatography (TLC) and high-performance liquid
chromatography (HPLC). Additionally, in vitro fecal fermentations revealed that strains
with a xylan1 phenotype can persist with xylan supplementation. These results indicate
that xylan1 B. pseudocatenulatum strains may have a competitive advantage in the complex environment of the gastrointestinal tract, due to their ability to act as primary
degraders of xylan through extracellular enzymatic degradation.
ABSTRACT

IMPORTANCE The beneﬁcial health effects of dietary ﬁber are now well established.
Moreover, low ﬁber consumption is associated with increased risks of metabolic and systemic diseases. This so-called “ﬁber gap” also has a profound impact on the composition
of the gut microbiome, leading to a disrupted or dysbiotic microbiota. Therefore, understanding the mechanisms by which keystone bacterial species in the gut utilize xylans
and other dietary ﬁbers may provide a basis for developing strategies to restore gut
microbiome function. The results described here provide biochemical and genetic evidence for primary xylan utilization by human-derived Biﬁdobacterium pseudocatenulatum
and show also that cooperative utilization of xylans occurs among other members of
this species.
KEYWORDS xylan, xylooligosaccharide, prebiotic, glycoside hydrolase, biﬁdobacteria,
cooperation, xylanase

X

ylans are a class of nondigestible polysaccharides that contain a xylose-based backbone
with b -1,4 glycosyl linkages. Linear homoxylans are uncommon in foods; rather, most
xylans appear in the diet as heteroxylans (1). These heteroxylans are decorated with a variety
of other sugars, including arabinose and glucuronic acid in the case of arabinoxylans and
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glucuronoxylans, respectively. Dietary xylan ﬁbers are found predominantly in monocots,
including cereal grains, although they can also be found at low levels in the peels of fruits
and vegetables (2, 3).
Xylans appear to have evolved as important substrates for fungi and bacteria in a variety of ecological biospheres, including seawater, alkaline hot springs, and the mammalian
digestive tract (4–6). These microbes employ enzymatic machinery that includes a combination of xylanases and accessory enzymes that work sequentially to degrade heteroxylan.
Xylanases are enzymes that cleave b -1,4 glycosyl linkages between consecutive xylose
units in the xylan backbone, while accessory enzymes remove side chains (7). Further xylan
degradation requires endoxylanases to cleave the interior regions of the xylan backbone
into xylooligomer fractions. These endoxylanases, identiﬁed via the carbohydrate-active
enzyme (CAZy) database, typically are found in the glycoside hydrolase (GH) families GH5,
GH10, GH11, GH30, and GH98 (8, 9).
In humans, xylans are resistant to digestion by digestive enzymes and reach the
large intestine intact; there, they are subject to colonic fermentation by members of
the gut microbiome (10). These fermenters can be broadly categorized as primary
degraders and secondary consumers, based on their ability to degrade xylan and transport and consume xylan hydrolysis products (11, 12). Primary degraders are capable of
direct consumption of xylan; most belong to the phyla Bacteroidetes, Actinobacteria,
and Firmicutes. For primary degradation of xylan, Bacteroidetes express extracellular
xylanases that are anchored to the outer membrane and near a SusC/SusD transport
system (13). This xylanase degrades xylan into small xylooligosaccharide (XOS) species
that are then transported by the SusC/SusD receptor into the periplasm, where further
dismantling of the oligosaccharide occurs. Similarly, primary degradation in Firmicutes
and Actinobacteria also relies on an anchored extracellular xylanase, but these Grampositive bacteria utilize substrate binding proteins and ATP-binding cassettes (ABC) or
phosphoenolpyruvate (PEP) phosphotransferase system (PTS) transporters to move
XOS substrates directly into the cytoplasm (9).
Other organisms are known to take advantage of the xylooligosaccharide products
produced by primary degraders via cross-feeding (14). These secondary consumers
include Gram-positive bacteria that lack key extracellular xylanolytic activity for direct
degradation of xylan. Two major groups of secondary consumers are Lactobacillaceae
and Biﬁdobacterium, which utilize highly specialized substrate recognition and transport systems for detection and transport of XOS (9). In vitro and in vivo studies suggest
that XOS is more effective at stimulating growth of Biﬁdobacterium species than
Lactobacillaceae, and XOS is also considered more selective than other prebiotic oligosaccharides (15–17). Even within Biﬁdobacterium, XOS utilization is highly speciﬁc, with
many XOS-metabolizing strains able to grow only on XOS with a low degree of polymerization (DP) (18). Therefore, growth on high-DP XOS and xylan fragments appears
to be a rare trait in Biﬁdobacterium.
Among Biﬁdobacterium species having such a phenotype are strains of Biﬁdobacterium
pseudocatenulatum. This species is generally considered an adult-type Biﬁdobacterium,
although strains have also been isolated from breastfed infants and children (19–21). This
species is clustered in the Biﬁdobacterium adolescentis phylogenetic group and has been
shown to ferment a diverse array of carbohydrate sources potentially present in the adult
diet (12, 22). Some strains have also been reported to have probiotic or health-promoting
properties (23–25).
We previously identiﬁed strains of B. pseudocatenulatum that were enriched in vitro
during growth on XOS (26). Preliminary experiments revealed that several of these
strains also grew well on longer-chain XOSs and xylan, indicating a potentially novel
phenotype in Biﬁdobacterium. Recently, very similar phenotypes were also described
for strains of this species (12). In this study, we extended these ﬁndings by comparing
the abilities of ﬁve B. pseudocatenulatum strains to grow on xylan and low-DP and
high-DP XOSs. Growth on these xylose-based substrates was dependent on the presence of relevant enzymes and corresponding gene clusters in their genomes. However,
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TABLE 1 Growth of ﬁve sequenced Biﬁdobacterium pseudocatenulatum strains on various
xylose-based carbohydrates
Growth of indicated straina
Substrate
Glucose
Xylose
Xylan
Short XOS (enriched in DPs of #4)
Long XOS (enriched in DPs of .4)
Arabinoxylan
Basal

ED01
111
2
2
11
1
2
2

ED02
111
11
11
111
111
2
2

ED03
111
2
11
111
111
2
2

CR16
111
2
2
11
1
2
2

ED05
111
2
2
11
1
2
2

aGrowth

phenotypes were based on optical density at 600 nm after 24 h of incubation in basal MRS containing
0.5% of the indicated carbohydrates. 2, growth at OD of ,0.1; 1, growth at 0.1. OD , 0.2; 11, growth at
0.2. OD , 0.45; 111, growth at OD of .0.45.

we also observed that strains that were unable to consume large-DP XOSs directly
could still grow on these substrates. This ﬁndings suggest that cross-feeding reactions
may provide a basis for cooperative utilization of these substrates within this species.
RESULTS
Growth characteristics of Biﬁdobacterium strains and isolates. We evaluated the
abilities of ﬁve B. pseudocatenulatum strains (ED01, ED02, ED04, ED05, and CR16), previously isolated from XOS enrichment experiments (see Materials and Methods), to grow
in modiﬁed deMan, Rogosa, and Sharpe (mMRS) broth containing xylan and XOS (Table 1).
Glucose was used as the positive control, while medium without added carbohydrates was
used as the negative control. All strains were able to grow on 0.5% XOS (XOS1), with strains
ED02 and ED03 displaying growth comparable to that on glucose (optical density at 600
nm [OD600] after 24 h . 0.45) on both short XOSs (SXOSs; enriched in members with a
DP of #4) and long XOSs (LXOSs; enriched in members with a DP of .4). In contrast, strains
ED01, CR16, and ED05 had moderate growth (arbitrarily assigned when the 0.2 ,
OD , 0.45) on SXOS and weak growth (0.1 . OD , 0.2) on LXOS. In addition, strains ED02
and ED03 were also able to grow on xylan (OD600 . 0.30) (xylan1), whereas strains ED01,
CR16, and ED05 demonstrated no growth (xylan2). Additionally, none of the strains grew
on arabinoxylan or in the negative controls. For subsequent experiments, ED01 and ED02
were selected as representative xylan2 and xylan1 strains, respectively (Fig. 1A).
In addition to the ﬁve selected strains, 10 additional B. pseudocatenulatum strains
isolated from different subjects and 9 strains of other Biﬁdobacterium species were
screened for growth on xylan, LXOSs, and xylose. Overall, the B. pseudocatenulatum
strains could be arranged into four phenotypes based on their growth on all three
xylan substrates (see Table S1 in the supplemental material). Interestingly, ED03 was
the only strain that had a xylan1 and XOS1 phenotype but did not grow on xylose.
Furthermore, in some instances, isolates obtained from the same subjects displayed
different growth phenotypes. Based on growth on xylan, LXOS, and xylose, the other
Biﬁdobacterium species were grouped into one of three additional phenotypes (Table
S1). However, none of these strains grew on xylan, and only three grew well on LXOS.
Genomic evidence for the presence of GH10 xylanases in Biﬁdobacterium. In silico analysis of carbohydrate-active gene clusters (CGCs) in the sequenced B. pseudocatenulatum genomes revealed the presence of three major clusters associated with XOS
utilization (Fig. 1B; Fig. S1). These three clusters contain substrate binding proteins,
transporters, and key glycosyl hydrolases that were shown to act on xylose-based substrates, as described in the CAZy database. First, we observed that the genomes of all
ﬁve strains contained all genes within XOS-active cluster III. This cluster includes genes
for a substrate binding protein, two ABC transporter permeases, a transcriptional regulator, and two GH43 glycosyl hydrolases. However, cluster I and cluster II were not
entirely conserved between the xylan1 and xylan2 strains. Compared to the case with
xylan1 strains ED02 and ED03, XOS active cluster I in strains ED01 and CR16 lacked
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FIG 1 Differences in growth phenotypes and XOS-active gene clusters between xylan1 ED02 and xylan2 ED01 B. pseudocatenulatum strains. (A) Growth of
B. pseudocatenulatum xylan1 strain ED02 (purple) and xylan2 strain ED01 (gray) on various xylose-based carbohydrates. Cells were grown in modiﬁed deMan,
Rogosa, and Sharpe (mMRS) medium supplemented with 0.5% carbohydrate. Basal medium, with no added carbohydrate, was used as a negative control, and
glucose was used as a positive control. Other carbohydrate treatments included xylose, short-chain XOS (enriched in DP less than 4), long-chain XOS (enriched
in DP greater than 4), xylan, and arabinoxylan. (B) Presence of XOS-active gene clusters between xylan1 and xylan2 phenotypes. Genes encoding XOS-active
clusters I, II, and III are aligned according to their phenotype and are color-coded for relevant carbohydrate-active functions.

genes that were orthologous to the substrate binding protein, multiple transporter
genes, and one glycosyl hydrolase gene (GH43).
Additionally, cluster II was found to be present only in the xylan2 strains ED01 and
CR16 and absent in ED05, while the xylan1 strains ED02 and ED03 harbor a homologous reducing-end xylose-releasing exo-oligoxylanase gene (GH8). Interestingly, a putative extracellular GH10 endo- b -1,4- xylanase gene was located adjacent to the GH8
xylanase gene present in the ED02 and ED03 genomes. Collectively, these results suggest that the extracellular GH10 gene is important for xylan metabolism and conﬁrm
that the presence or absence of key glycosyl hydrolases and transport systems is consistent with the observed phenotypes.
A pangenome analysis with 86 B. pseudocatenulatum genomes from the NCBI database and 5 genomes from this study was conducted to further investigate the prevalence of these XOS-associated genes and CGCs in the B. pseudocatenulatum species.
This analysis revealed the presence of 5,620 genes consisting of 1,227 core genes (present in all 86 genomes), 2,965 shell genes (present in 2 to 85 genomes), and 1,428 cloud
genes (present in only one genome). Among these genomes, only 19 contained a
GH10-encoding gene, including the two xylan1 strains in this study (Fig. S2). In addition, these results indicated differences in the prevalence of each XOS-active gene cluster in B. pseudocatenulatum species. For example, cluster III was highly conserved and
was found to be present in all strains. Cluster I was the second most prevalent, with 64
of 86 genomes containing the complete cluster, followed by cluster II, which was
found to be complete in 33 of the 86 genomes (Fig. S2A). However, the GH8 reducingend xylose-releasing exo-oligoxylanase gene was found to be present in 50 of the 86
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genomes. This includes all 19 genomes where the GH10-encoding gene was present as
observed in the xylan1 ED02 and ED03 strains (Fig. S2B).
To investigate the prevalence of GH10 in other Biﬁdobacterium genomes, 1,355
Biﬁdobacterium genomes from NCBI RefSeq were screened for the presence of GH10
xylanases. This analysis revealed that a GH10 xylanase-encoding gene was found to be
present in only 29 genomes (2.14%), including 17 B. pseudocatenulatum, 4 B. catenulatum, 3 B. pullorum, and 2 B. adolescentis strains. Single genomes from B. reuteri,
Biﬁdobacterium animalis subsp. lactis, and one Biﬁdobacterium species were also found
to contain a GH10 xylanase gene (Fig. S3).
Biochemical evidence of xylan utilization and cross-feeding. Both in vitro growth
experiments and in silico genome analysis indicated that the xylan1 phenotype was
dependent on a putative extracellular xylanolytic system. To conﬁrm the presence of
an extracellular xylanase, cell-free supernatants were obtained from all ﬁve representative strains. When MRS broth containing LXOS was supplemented with these supernatants and assessed by thin-layer chromatography (TLC), hydrolysis products ranging
from DP2 to D4 were observed only for the ED02 or ED03 supernatants (Fig. 2A). The
same activity was also observed on xylan, where only the xylan medium inoculated
with the xylan1 supernatant resulted in xylan hydrolysis products (Fig. 2B). When the
supernatant was heat treated, no hydrolysis products were formed, conﬁrming that hydrolysis was due to the presence of extracellular xylanases.
The presence of an ED02 xylanase and its activity on XOS and xylan were also demonstrated by high-performance liquid chromatography (HPLC) analysis of hydrolysis
products. The results indicated an increase in the concentration of DP2 -4 XOS products, similar to the TLC results. In addition, HPLC revealed a decrease in DP5 -13 XOS
fragments from the xylanase-treated LXOS, as well as production of DP2 -6 products
from xylan (Fig. 2C; Fig. S4). When this medium was then inoculated with the xylan2
strain ED01, enhanced growth on both substrates was observed (Fig. 2D).
Persistence of strains in fecal fermentation is consistent with phenotypes in
pure culture. Fecal fermentations across all three xylose-based substrates combined
with either strain ED01 or ED02 were performed to test for strain persistence within a
complex fecal community. Persistence of strains during these stepwise fecal fermentations containing ﬁve different donor samples was consistent with their xylan and LXOS
phenotypes. Xylan1 strain ED02 persisted on LXOS for all ﬁve donor samples (Fig. 3D)
and on xylan for four of the ﬁve donor samples (Fig. 3F) but was displaced during
growth in basal medium (Fig. 3B). In contrast, strain ED01 was displaced in fermentations containing LXOS or xylan as well as the basal fermentations (Fig. 3A, C, and E).
Samples at baseline and at the 72-h time point for the ﬁve fecal-fermentation samples were sequenced via 16S rRNA amplicon sequencing to assess changes in the microbial community. For all samples at 72 h, signiﬁcant decreases in alpha diversity
(Shannon index) were observed compared to baseline samples (P , 0.05) (Fig. 4A).
Similarly, alpha diversity of all substrate-only fermentations was signiﬁcantly different
from baseline, presumably because the method also selects for taxa resistant to dilution pressure (Fig. 4B). Additionally, the XOS treatment was signiﬁcantly less diverse
than the basal treatment. (P , 0.01). Beta diversity was evaluated using principal-coordinate analysis (PCoA) based on Jaccard distance to compare differences in community
composition between substrate treatments (Fig. 4C). As expected, the fecal baseline
clustered distinctly from the substrate treatments. Interestingly, the XOS-treated fermentation samples also clustered separately from the basal treatment, while the xylantreated samples overlap between the two.
Biﬁdobacterium was detected in all ﬁve fecal baseline samples and was initially present at greater than 5% relative abundance in subjects A33 and A35 (Fig. S5). After 72 h
of stepwise growth in basal fecal-fermentation medium with no added carbohydrates,
the relative abundance of Biﬁdobacterium decreased for both ED01 and ED02 treatments, as well as fermentations with no added strain. Based on differential analysis comparing basal fecal-fermentation samples at baseline to those at 72 h, a method effect
was apparent. Speciﬁcally, there were consistent increases in various fast-growing taxa,
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FIG 2 Production of endoxylanase and extracellular xylanase in B. pseudocatenulatum ED02 supports cross-feeding relationships between xylan1 and
xylan2 strains. Shown are thin-layer chromatography (TLC) results of supernatant inoculated media containing either LXOS (lane 1, LXOS medium; lanes 2
to 6, LXOS media inoculated with respective strain supernatant; lane 7, 15 mM XOS standards DP1 to DP6; lane 8, basal medium) (A) or xylan (lane 1,
xylose; lane 2, 15 mM XOS standards DP1 to DP6; lane 3, xylan medium; lane 4, xylan medium inoculated with ED02 supernatant; lane 5, xylan medium
inoculated with heat-treated ED02 supernatant) (B). The chromatograms are composite of lanes from the same TLC plate. (C) Growth of xylan2 strain ED01
in the presence (red) or absence (gray) of ED02 supernatant-inoculated LXOS (dashed line) and xylan (solid line). (D) High-performance liquid
chromatography (HPLC) indicates endoxylanase activity by ED02 producing small XOS fractions. Degradation products by ED02 supernatants after 48 h of
incubation with XOS were separated and quantiﬁed by HPLC. In the XOS media, DP2 to -4 increased and DP5 to -13 decreased. Trends are indicated by
arrows, displaying change in area under the curve from time zero to 48 h.

including amplicon sequence variants (ASVs) from the genera Escherichia-Shigella,
Enterococcus, Streptococcus, and Fusobacterium (Fig. S5 and S6). Other method effects
included signiﬁcant decreases in several ﬁber-associated bacteria, including Roseburia,
Akkermansia, and Prevotella (Fig. S6).
Biﬁdobacterium was enriched with XOS supplementation for two (A33 and A35) of
the ﬁve donor samples even in the absence of an inoculated strain (Fig. S5). Relative
abundances of Biﬁdobacterium also increased in all subjects when fecal fermentations
were inoculated with strains ED01 and ED02. Three Biﬁdobacterium ASVs were identiﬁed
from the fecal fermentations and were assigned as B. pseudocatenulatum, B. adolescentis,
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FIG 3 Test of persistence of B. pseudocatenulatum strains in fecal fermentations. Shown is qPCR quantiﬁcation
of strains ED01 and ED02 on basal medium (A and B), XOS (C and D), and xylan (E and F) in fecal
fermentations with samples from 5 subjects. Persistence in individual fecal samples is shown as solid lines
with colored circles, and averages are shown as dashed lines with square symbols. Signiﬁcant differences
between 24 h and 72 h were determined using a repeated-measure mixed model (*, P , 0.05; **, P , 0.01;
***, P , 0.001).

and B. longum according to sequence similarity and the number of species-speciﬁc taxonomic hits against the NCBI nonredundant (nr) database (Table S3). The B. pseudocatenulatum ASV increased signiﬁcantly in both ED01 and ED02 supplemented XOS media,
while signiﬁcant increases in the other two Biﬁdobacterium ASVs were not observed in
the presence of XOS.
On xylan, the relative abundance of Biﬁdobacterium for all ﬁve subjects in both the
control treatment and ED01 treatment decreased by the 72-h time point, accompanied
by an observed decrease in two Biﬁdobacterium ASVs (B. adolescentis and B. longum)
from the differential abundance analysis (Fig. S5 and S6). In the ED02 treatment with
xylan, there was an increase in relative abundance of Biﬁdobacterium in subjects A31,
A33, A34, and B39 but a decrease in subject A35. However, no signiﬁcant change in
any B. pseudocatenulatum-associated ASV was observed from the differential-abundance
analysis (Fig. S6). Instead, a signiﬁcant reduction was observed for a Biﬁdobacterium ASV (B.
adolescentis) that was present at baseline.
DISCUSSION
The importance of xylans as dietary substrates for gut microbes has led researchers
to identify and characterize strains having the biochemical and genetic means to
metabolize these carbohydrates (14, 19, 27). In this study, two major xylan phenotypes
were observed among strains of the human gut-residential species B. pseudocatenulatum. Strains having a xylan1 phenotype were considered primary degraders, hydrolyzing xylan via an extracellular GH10 xylanase and forming XOS fractions of various DPs.
This is consistent with the activity of GH10 xylanases described previously (28–30).
Furthermore, growth of the xylan1 strain ED02 directly on xylan, as well as LXOS, indicated this strain could also consume small- and large-DP hydrolysis products. Comparative
genome analysis of the B. pseudocatenulatum strains revealed the presence of three XOSOctober 2022 Volume 88 Issue 20
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FIG 4 Analysis of microbial diversity and community composition through 16S rRNA sequencing of fecal
fermentations at baseline and 72 h. (A and B) Shannon index was used to measure alpha diversity, and
comparisons were made between strain (A) and substrate (B) treatments with baseline and respective
controls. Signiﬁcant differences are indicated by asterisks (Wilcoxon rank sum test with false-discovery rate
[FDR] correction; *, P , 0.05; **, P , 0.01; ***, P , 0.001). (C) Beta diversity between substrates was
visualized by principal-coordinate analysis (PCoA) based on Jaccard Index. Ellipses indicate 95% conﬁdence
intervals.

associated clusters, consistent with those described previously (27). In this study, both cluster I and cluster III were present in xylan1 strains and contained substrate binding proteins
with predicted afﬁnities for LXOS and SXOS, respectively. In addition, the GH8, GH43, and
GH120 glycoside hydrolases present in these XOS-active clusters are likely used to degrade
intracellular XOS into xylose.
In contrast to ED02, which was a primary degrader as well as consumer of xylan,
other strains had a xylan2 phenotype but could still grow on XOS. These strains were
considered secondary consumers. Thus, in complex communities where xylans are
hydrolyzed by primary degraders, secondary consumers obtain substrates via crossfeeding (Fig. 5) (11, 14). This was demonstrated by enhanced growth of strain ED01 on
LXOS and xylan in the presence of the extracellular xylanase produced by ED02. These
xylan2 strains likely employ the same XOS transport systems encoded in cluster III as
xylan1 strains, since this cluster is highly conserved in Biﬁdobacterium (27). Moreover,
the possibility that exchange of these genes occurs more frequently among populations who frequently consume xylan or other nondigestible carbohydrates has recently
been proposed (31).
Interestingly, we observed that all strains examined in this study grew better on
XOS than on xylose. Biﬁdobacterium organisms are well known to have adapted to the
gut environment, where simple sugars are absent and oligosaccharides, including XOS,
are more abundant. For example, B. adolescentis was shown to have higher speciﬁc
growth rates on fructooligosaccharides than on fructose (32). Likewise, a strain of
Biﬁdobacterium longum subsp. infantis was shown to grow better on human milk oligosaccharides than on glucose (33). These ﬁndings strongly support the evolutionary adaptation of Biﬁdobacterium to grow on a range of oligosaccharides which is reﬂected
by the presence of relevant transporters and associated transport machinery in their
genomes (34–36).
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FIG 5 Model for xylan and XOS utilization by B. pseudocatenulatum. The xylan1 phenotype is implicated as a primary degrader due to the secretion of an
extracellular xylanase that degrades xylan into smaller oligomers. The latter are available for transport by the primary degrader, or they can cross-feed
other organisms. In contrast, strains having a xylan2 phenotype may still be secondary consumers. Such strains do not have the extracellular enzymatic
machinery or transporters to consumer larger XOS and xylan molecules; they instead rely on other members of the microbial community to degrade xylans
into smaller oligosaccharides that can serve as substrates for relevant transporters.

Recently, other investigators reported the presence of a XOS cluster containing GH8
and GH10 xylanases in B. pseudocatenulatum, although as in our study, this cluster was
only present in a portion of the strains examined (12, 37). In one study (37), which surveyed a total of 217 strains of Biﬁdobacterium from six human-origin species, the GH10
xylanase was found in only 9 of 30 B. pseudocatenulatum strains and was absent in all
other Biﬁdobacterium strains. Moreover, in another recent study, despite the presence
of 30 glycoside hydrolase families, GH10 xylanases were not detected in any of the 88
strains of B. pseudocatenulatum examined (38). From our in silico analyses, putative GH10
xylan-containing species also include B. catenulatum, B. adolescentis, B. pullorum,
B. animalis subsp. lactis, and B. reuteri. In particular, B. catenulatum and B. adolescentis, along
with B. pseudocatenulatum, belong to the B. adolescentis phylogenetic group that are considered adult-type biﬁdobacteria (39). Thus, the ability of these strains to metabolize xylan
would be consistent with the consumption of dietary ﬁber in the adult human diet (18, 19).
In another recent study, 12 of 35 B. pseudocatenulatum strains harbored a GH10
xylanase and also grew on long-chain xylan as well as wheat arabinoxylan as a carbohydrate substrate (12). This arabinoxylan growth phenotype was not observed in our
study, which may be attributed to the use of corn arabinoxylan, a more complex substrate than wheat arabinoxylan. Previous studies suggest that corn arabinoxylans are
indeed more resistant to xylanase hydrolysis (40, 41). Thus, it is possible that the strains
used in our study may have had a similar phenotype on wheat arabinoxylans as the
strains used in the previous study (12).
The ability of B. pseudocatenulatum ED02 to grow on xylan or LXOS likely provides a
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TABLE 2 Substrates used in this study
Substrate
SXOS
LXOS
PreneXOS
Xylan
Arabinoxylan

Label
XOS-NUSR
XOS-NUSP
PreneXOS
Xylan (Beechwood)
AgriFiber BFG

Supplier
Prenexus Health
Prenexus Health
Prenexus Health
Megazyme
AgriFiber

Xylose
Glucose

D-(1)-xylose

Sigma
Sigma-Aldrich

D-(1)-glucose

Composition
Short-chain XOS; enriched in DPs of ,4
Long-chain XOS; enriched in DPs of .4
Mixture of XOS and xylan
Glucuronoxylan from beechwood
Soluble prebiotic corn bran ﬁber; DP17
to -24
Xylose
Glucose

competitive advantage in mixed cultures or complex environments containing XOS as
the carbohydrate source. However, xylan2 strains also beneﬁtted from the activity of
xylan1 strains. That one strain supports growth of another strain within the same ecosystem by degrading xylan-rich substrates suggests that cross-feeding and cooperation
exist within the B. pseudocatenulatum group, similar to what has been described for
Bacteroides during growth on glucose and fructose polysaccharides as well as xylantype polysaccharides (14, 42). In our study, the observation of within-species cooperation was further supported by the in vitro stepwise fecal fermentations. Although ED01
failed to persist with xylan as a substrate, this strain persisted on XOS, suggesting that
if primary xylan degraders were present, secondary XOS consumers would have sufﬁcient substrate to grow and persist.
Collectively, our ﬁndings extend previous reports on the role of B. pseudocatenulatum
in the degradation and utilization of xylan and xylan-derived oligosaccharides. We provide
biochemical evidence for a GH10 xylanase produced by human-origin Biﬁdobacterium and
showed that these strains can cross-feed non-GH10-producing strains of the same species.
Thus, cooperative utilization of xylan among different strains of B. pseudocatenulatum suggests that resource sharing, a trait common to biﬁdobacterial communities (43), can also
occur within a single species.
MATERIALS AND METHODS
Isolation and identiﬁcation of Biﬁdobacterium isolates. Fifteen putatively unique Biﬁdobacterium
isolates from ﬁve adult subjects were used in this study. These isolates had been previously obtained
(26) from in vitro fecal enrichment fermentations with 1% XOS (Prenexus Health, USA) and presumptively identiﬁed as B. pseudocatenulatum by 16S rRNA sequencing. To conﬁrm species identity, DNA was
extracted with a QIAamp DNA minikit (Qiagen, USA), and quantitative PCR (qPCR) was performed using
B. pseudocatenulatum-speciﬁc primers (44). One isolate from each subject was selected as the representative strain for further genomic and functional analysis. These strains were renamed ED01, ED02, ED03,
CR16, and ED05. In addition to the B. pseudocatenulatum isolates, 11 other Biﬁdobacterium strains were
assessed for their ability to utilize xylose-based glycans.
Growth characteristics of Biﬁdobacterium strains and isolates. To characterize the ability of B.
pseudocatenulatum strains to utilize xylose-based glycans, growth studies were performed in modiﬁed
de Man, Rogosa, and Sharpe media (mMRS) in which glucose was replaced with various carbohydrates
(Table 2). Strains were ﬁrst grown on MRS plates for 48 h, and single colonies were inoculated into MRS
broth and incubated anaerobically at 37°C for 24 h in a Sheldon Bactron IV-900 anaerobic chamber
(Cornelius, OR, USA). Cells were then transferred into MRS, and overnight cultures were used to inoculate
mMRS containing 0.5% carbohydrate. Growth experiments were performed in quadruplicate, with a ﬁnal
volume of 200 m L, in 96-well microplates. Plates were incubated anaerobically, and optical density measurements (600 nm) were obtained every 20 min using a Tecan (Männedorf, Switzerland) Sunrise microplate reader until stationary phase was reached.
Growth phenotypes of other Biﬁdobacterium species on xylose-based substrates were determined
by growth in mMRS containing xylan, LXOS, or xylose at a 1% concentration. Experiments were performed, in triplicate, in 200-m L microwell volumes, and phenotypes were based on growth and pH.
Xylan and XOS DP2 to -6 standards were obtained from Neogen Megazyme (USA), and SXOS and LXOS
were obtained from Prenexus Health.
DNA extraction. Genomic DNA from isolated strains and for pure culture experiments was extracted
with the QIAamp DNA minikit using the manufacturer’s protocol for Gram-positive bacteria (Qiagen,
Hilden, Germany). For fecal-culture experiments, DNA was extracted using BioSprint 96 One-For-All Vet
kits (Qiagen) according to the manufacturer’s protocol, with modiﬁcations as described previously (45).
Sample concentrations were quantiﬁed using a NanoDrop ND-1000 spectrophotometer.
Whole-genome sequencing, assembly, and annotation. Whole-genome sequencing of the ﬁve
selected B. pseudocatenulatum strains was performed by the Microbial Genome Sequencing Center (MiGS).
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Raw read sequences were checked for read quality using FastQC (46), and the sequences were trimmed
using Sickle to remove low-quality reads (47). The reads were assembled into contigs and scaffolds using
SPAdes (48). Scaffolds were aligned using Mauve against the reference genome B. pseudocatenulatum 12
retrieved from the NCBI database (49). The assembled genomes were annotated using Prokka (50). A summary of features for each strain is shown in Table S2. Additional annotations against the carbohydrateactive enzyme (CAZy) database were obtained using dbCAN2 to identify CAZy clusters (51).
B. pseudocatenulatum pangenome analysis. Pangenome analysis was performed using 86 B. pseudocatenulatum genomes. The genomes included those of the 5 strains reported here and 81 additional
B. pseudocatenulatum genomes from the Prokaryotic RefSeq Genomes database in NCBI (52).
Pangenomic analyses were performed with anvi’o with the MCL (Markov cluster) algorithm using an
inﬂation parameter of 10 to identify and cluster amino acid sequences between genomes (53, 54).
Further annotations were performed using dbCAN2 to identify prevalence of XOS active clusters in the
B. pseudocatenulatum pangenome (51).
Prevalence of GH10 xylanase in Biﬁdobacterium. To determine the prevalence of GH10 xylanases
in Biﬁdobacterium, 1355 nonredundant Biﬁdobacterium genomes were obtained from the Prokaryotic
RefSeq Genomes database from NCBI (52). These genomes were annotated with three CAZy databases,
HMMER, DIAMOND, and Hotpep, using the dbCAN2 metaserver (51, 55–57). A genome was considered
to contain GH10 if at least two CAZy databases concurred. Species level associations were then
assigned.
Assessing enzymatic activities. To determine if extracellular enzymes capable of hydrolyzing XOS
or xylan were secreted, cell-free supernatants were obtained from spent XOS cultures. Strains were
grown anaerobically at 37°C in mMRS supplemented with 1% LXOS in 10-mL volumes for 24 h. Cultures
were centrifuged (Eppendorf AG, Hamburg, Germany) at 3,100  g for 10 min. Supernatants were collected, ﬁlter sterilized through a 0.22-m m ﬁlter, and divided into aliquots. One aliquot was used directly
(see below), and the second was heat treated at 95°C for 5 min to inactivate enzymes.
Identiﬁcation of hydrolysis products. Basal mMRS containing 1% xylan or 1% LXOS was supplemented with 20% supernatant that was either heat treated or not heat treated. Samples were obtained
at time zero and after 48 h of incubation at 37°C. All samples were then heat treated, as described
above, to halt further enzymatic activity and then stored at 220°C. Identiﬁcation of hydrolysis products
was done using high-performance thin-layer chromatography silica gel 60 (Sigma-Aldrich, St. Louis, MO),
as described previously (26). Brieﬂy, plates were spotted with 8.5 m L of medium and supernatant-inoculated medium and 5 m L of standards, including 2% xylose and 10 m M XOS DP1 to -6 standards (Neogen
Megazyme). Plates were developed in solvent containing 1-butanol–2-propanol–H2O (3:12:4), sprayed
with 0.5% a-naphthol and 5% H2SO4, and heated at 80°C for 30 min.
Selected samples were also analyzed by high-performance liquid chromatography (HPLC) at the
National Renewable Energy Laboratory (NREL). The HPLC system included a Waters Acquity ultraperformance LC (Waters Co., Milford, MA, USA) coupled with a mass spectrometer (MS) and an evaporative
light scattering detector. The system ran with a Shodex sugar SZ5532 (zinc) column (Showa Denko K.K.,
Japan) at 6 by 150 (mm), 6-m m particle size, using a ramped mobile phase of acetonitrile and water with
0.1% formic acid with a ﬂow rate of 0.9 mL min21 and a column temperature of 60°C. DP fractions were
identiﬁed via molecular weight and retention time from standards. Detector responses recorded enzymatic action observed by changes in area under the chromatogram curves from baseline to 48 h.
Coculture simulation of B. pseudocatenulatum strains. To assess if cross-feeding was occurring
between strains, growth curves were performed using the enzymatic supernatants described above.
Supernatants were added at 20% to fresh medium containing 1% LXOS or xylan. The medium was then
inoculated with xylan-non-fermenting strains and incubated for 48 h.
In vitro establishment of B. pseudocatenulatum strains. Fecal samples were obtained from ﬁve
volunteers following UNL institutional board review (IRB) protocols (no. 20160616139). Inclusion criteria
included the following: age of at least 19 years, no known history of gastrointestinal diseases, no consumption of antibiotics or probiotics in the previous 6 months, and no regular consumption of yogurt.
The fecal samples were then homogenized and stored in phosphate-buffered saline (PBS; pH 7.0), as previously described (26).
Sterile fecal-fermentation medium containing 0.5% LXOS or xylan or no added carbohydrate was
made as described previously (58). The test of persistence was performed in stepwise fecal fermentations
as described previously (21). Brieﬂy, fecal slurries were diluted in PBS in a 1:10 ratio and added to the fermentation medium in a 3:6 (vol/vol) ratio in a total volume of 9.0 mL. Then, B. pseudocatenulatum strains
ED01 and ED02, grown as previously described, were inoculated at 107 CFU/mL into the fecal-fermentation
medium. The fermentations were incubated anaerobically at 37°C, with subsequent dilutions performed in
microplate format by transferring 10 m L into 990 m L of fresh fermentation medium every 24 h. This process
was repeated three times, with samples collected at time zero and 24, 48, and 72 h. DNA was extracted to
assess persistence by qPCR. Samples were also used for 16S rRNA sequencing.
Design of strain-speciﬁc primers. Strain-speciﬁc primers were designed using RUCS (rapid identiﬁcation of PCR primers for unique core sequences) (59). All ﬁve isolated B. pseudocatenulatum genomes
and two complete B. pseudocatenulatum genomes from the NCBI genome database were used to identify unique target sequences. Primer speciﬁcity was conﬁrmed using NCBI Primer BLAST against the
NCBI RefSeq representative genome database for bacteria. No primers were accepted that gave hits for
species present in human fecal samples. Primer annealing temperatures were identiﬁed using a gradient
PCR program, and primer speciﬁcity was conﬁrmed by performing qPCR against all other B. pseudocatenulatum strains isolated.
October 2022 Volume 88 Issue 20

10.1128/aem.01299-22

11

Xylan and Xylooligosaccharide Utilization by Biﬁdobacteria

Applied and Environmental Microbiology

TABLE 3 PCR conditions and sequences used to target different Biﬁdobacterium groups in this study
Primer
Target organism
B. pseudocatenulatum ED01
B. pseudocatenulatum ED02
B. pseudocatenulatum ED03
B. pseudocatenulatum CR16
B. pseudocatenulatum ED05
B. pseudocatenulatum
Biﬁdobacterium

Direction
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

Sequence (59 ! 39)
CAG CCA AGA ACA CAC TGC
GCA TGG CAA CTG TCT TCG TTT
GCA GGT CAG AAT GTG AGA CGA
CGA ACC TCT GTC CAA CGA TGA
CTT GCT GGG AGA AGT CGT CTT
TCG ATT TGT TCC GTT CGT
AAG GCT CGT GTT ATC CGG TTT
GCG CTT CGA AAT CCT GTG TAC
CGA TTC GAC AAC ACG TAC ACG
TCA GAT GTT TGT CCG CTT CGA
AGC CAT CGT CAA GGA GCT TAT CGC AG
CAC GAC GTC CTG AGA GCT CAC
TCG CGT CYG GTG TGA AAG
CCA CAT CCA GCR TCC AC

Annealing
temp (°C)
62

Reference
This study

62

This study

62

This study

62

This study

62

This study

68

44

68

26

Quantiﬁcation using quantitative real-time PCR. To determine persistence of speciﬁc strains and
total Biﬁdobacterium in fecal fermentations on different substrates, qPCR was performed using strainspeciﬁc and genus-speciﬁc primers (Table 3). Quantitative PCR was performed using these primers with
the Mastercycler Realplex2 (Eppendorf AG, Hamburg, Germany). The qPCR master mix contained 12.5
m L of SYBR green (Thermo Fisher Scientiﬁc, MA, USA), 0.5 m L of forward primer, 0.5 m L of reverse primer,
10.5 m L of DNA-grade water, and 1 m L of sample, in a total volume of 25 m L per reaction. The qPCR conditions were as previously described (44).
Persistence of strains on respective substrates was analyzed using a repeated-measure mixed model.
This model relegates subject as the random effect, while prebiotic and time are ﬁxed effects. Persistence
was measured as the log10 difference in CFU per milliliter of strains between the 24- and 72-h samples.
Calibration curves for strain-speciﬁc growth were obtained using diluted DNA samples collected from
pure culture growth on modiﬁed MRS of ED01 and ED02, respectively. Analysis was performed using
SAS v.9.4, and P values were adjusted with Tukey adjustment.
16S rRNA amplicon sequencing and analysis. Sequencing of the V4 region of the 16S rRNA gene
was carried out as described previously on an Illumina MiSeq platform with paired-end sequencing of
250 bp (26, 60). Fecal-fermentation samples at the 72-h time point and the ﬁve fecal baselines were
selected for analysis. A total of 1,292,111 sequences were obtained, with a mean of 25,335 sequences
per sample (maximum, 73,706; minimum, 7,061).
Sequence processing was performed using the DADA2 pipeline within QIIME2 2017.4 (61, 62). Raw
sequence data were demultiplexed and denoised to remove chimeric sequences, and forward and
reverse reads were trimmed to 220 bp and 160 bp, respectively. Amplicon sequence variants (ASVs)
were inferred and taxonomy was assigned using the SILVA 16S database (63). To further reﬁne output,
samples with fewer than 1,500 reads and ASVs with fewer than 15 reads were removed.
Statistical analysis and visualization of community sequencing data were done in QIIME2 2017.4 and
RStudio (v.4.0.0). Alpha diversity was measured via the Shannon index and compared via a Wilcoxon
rank sum test. Beta diversity was visualized using a principal-coordinate analysis (PCoA) plot of the
Jaccard index with 95% conﬁdence interval ellipses for the respective treatments. Changes in microbial
composition from baseline to 72 h were visualized by log2 fold change of speciﬁc ASVs with a signiﬁcance cutoff of P value ,0.05 using DESeq2.
Data availability. Whole-genome sequences and 16S rRNA sequences have been submitted to
GenBank under BioProject PRJNA820700.
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Supplemental material is available online only.
SUPPLEMENTAL FILE 1, PDF ﬁle, 2 MB.
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